Free Trial

Q2 Earnings Forecast for Vital Farms Issued By William Blair

Vital Farms logo with Consumer Staples background

Vital Farms, Inc. (NASDAQ:VITL - Free Report) - Research analysts at William Blair reduced their Q2 2025 earnings per share estimates for Vital Farms in a report released on Thursday, May 8th. William Blair analyst J. Andersen now anticipates that the company will post earnings of $0.25 per share for the quarter, down from their prior forecast of $0.27. William Blair has a "Outperform" rating on the stock. The consensus estimate for Vital Farms' current full-year earnings is $1.11 per share. William Blair also issued estimates for Vital Farms' Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.38 EPS and FY2026 earnings at $1.50 EPS.

Several other equities research analysts also recently issued reports on VITL. Telsey Advisory Group reiterated an "outperform" rating and issued a $52.00 price objective on shares of Vital Farms in a report on Monday, May 5th. DA Davidson cut their price objective on Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a report on Friday, March 14th. Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective on the stock in a report on Friday, February 28th. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a report on Tuesday, May 6th. Finally, Morgan Stanley cut their price objective on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Vital Farms has an average rating of "Buy" and a consensus price target of $44.63.

Get Our Latest Report on Vital Farms

Vital Farms Price Performance

VITL stock opened at $33.82 on Monday. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.51 billion, a PE ratio of 30.20 and a beta of 0.94. Vital Farms has a 12-month low of $27.91 and a 12-month high of $48.41. The business's fifty day moving average price is $32.50 and its 200 day moving average price is $35.07.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.11. The company had revenue of $162.19 million for the quarter, compared to the consensus estimate of $164.43 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company's revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.43 earnings per share.

Institutional Trading of Vital Farms

Large investors have recently made changes to their positions in the company. CIBC Private Wealth Group LLC raised its stake in Vital Farms by 152.1% during the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after acquiring an additional 540 shares during the last quarter. US Bancorp DE raised its stake in Vital Farms by 160.3% during the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after acquiring an additional 872 shares during the last quarter. Frazier Financial Advisors LLC purchased a new stake in Vital Farms during the 4th quarter valued at approximately $59,000. Mendota Financial Group LLC purchased a new stake in Vital Farms during the 4th quarter valued at approximately $62,000. Finally, Principal Securities Inc. raised its stake in Vital Farms by 29.4% during the 4th quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock valued at $63,000 after acquiring an additional 380 shares during the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Matthew Ohayer sold 20,000 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $29.46, for a total transaction of $589,200.00. Following the completion of the transaction, the insider now directly owns 6,970,890 shares of the company's stock, valued at approximately $205,362,419.40. This represents a 0.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Russell Diez-Canseco sold 45,124 shares of the company's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $33.69, for a total value of $1,520,227.56. Following the completion of the sale, the chief executive officer now directly owns 703,736 shares of the company's stock, valued at approximately $23,708,865.84. This trade represents a 6.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 93,124 shares of company stock valued at $3,019,308 in the last three months. 27.60% of the stock is owned by corporate insiders.

About Vital Farms

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Read More

Earnings History and Estimates for Vital Farms (NASDAQ:VITL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines